High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome
- Conditions
- Acute Coronary Syndrome
- Registration Number
- NCT06673381
- Lead Sponsor
- Sohag University
- Brief Summary
assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients
- Detailed Description
Observational study conducted at coronary care unit(CCU) in sohag university hospital It included patients with ACS diagnosed according to AHA/ACCF guidelines (according to symptoms, ECG findings and serum troponin levels), who had admitted to the CCU.
Venous blood samples were instantly collected on admission to the hospital. hs-CRP , serum albumin level were measured.
hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR) In-hospital MACE was regarded as the end point of our study. It was defined as acute heart failure, cardiogenic shock, reinfarction, all-cause death, serious arrhythmia and cardiac death
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 240
- All patients aged 18 Year or older presented by ACS not candidet for primary percutaneus coronary intervention ( PCI ) .
-
• Patients aged < 18 years old
- Patients who have eGFR <60 ml/kg /m2
- Patients who have malignancies
- Patients who have chronic heart failure (NYHA class >II)
- Pateints who have chronic liver disease
- Patients who have nephrotic syndrome
- Patients who have acute cerebrovascular stroke
- Pregnant women
- Patients who have recent infection
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in acute coronary syndrom patients at time of admission in hospital Venous blood samples were collected on admission to the hospital. hs-CRP , serum albumin level were measured.
hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sohag faculty of medicine
🇪🇬Sohag, Egypt